When should you stop taking Mounjaro — and how do you know it's time?

What does the clinical guidance actually say about stopping?

NICE, in its appraisal of tirzepatide (TA1026), is unusually specific on this point. If a person has not lost at least 5% of their starting body weight after six months at the highest dose they can tolerate, the guidance says continuing treatment should be reassessed. That is a clinical checkpoint, not a suggestion. Your prescriber will review it.

Beyond that threshold, NICE does not set a hard upper time limit on tirzepatide treatment in the way it does for semaglutide. That means some people stay on Mounjaro well beyond a year, particularly if they are managing a weight-related condition alongside weight loss, and our page on how long you should stay on Mounjaro explores what that longer-term picture looks like in practice. The decision is always individual.

The NHS medicines page for tirzepatide is worth reading before you make any changes: it covers what to do if you are unsure, and why you should always speak to your prescriber rather than stopping abruptly without guidance. There is no medical risk in stopping tirzepatide suddenly (it is not addictive) but doing it without a plan rarely ends well for the progress you have made.

Are there side effects serious enough to stop immediately?

Most gastrointestinal side effects (nausea, loose stools, indigestion) are most noticeable after a new dose starts and often ease within a week or two. They are uncomfortable but are not, on their own, a reason to stop. The picture changes if symptoms are severe or persistent.

The one side effect that warrants stopping and getting urgent help is severe stomach pain that doesn't ease and spreads towards the back, with or without vomiting. This can signal acute pancreatitis, which the MHRA identified in a January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. If that happens, do not wait for your next review appointment.

Other reasons to stop and contact a clinician promptly include signs of a serious allergic reaction, gallbladder symptoms (sudden intense pain in the upper right abdomen), or significant dehydration following severe vomiting or diarrhoea. You can report any suspected side effect through the MHRA Yellow Card scheme, which helps the regulator track emerging safety signals across the patient population.

If you are unsure whether what you are experiencing is serious, contacting our aftercare team is the right move, we are available seven days a week. Details are on the contact page.

What happens to your weight when you stop, and what should you do about it?

This is probably the question our prescribers hear most often. Mounjaro works by suppressing appetite through GIP and GLP-1 receptor pathways; when you stop, both pathways are no longer being activated, and hunger typically returns. Research on GLP-1 medicines consistently shows that a portion of lost weight returns after stopping, though the amount varies considerably between individuals.

That does not mean stopping is always wrong. It does mean that having a plan matters. Stopping Mounjaro in a managed way (with dietary habits embedded, activity built in, and ideally continued prescriber support) puts you in a better position than stopping abruptly because you ran out of pens or the cost felt too high one month. If you are wondering not just whether to stop but how long you should use Mounjaro in the first place, that guidance covers treatment duration in more detail.

There is also the practical side. For people whose weight is tied to a medical condition (high blood pressure, sleep apnoea, type 2 diabetes) stopping treatment may affect those conditions too. That conversation belongs with your prescriber, not a forum.

Are there personal circumstances that make stopping the right call?

Yes. Pregnancy is the clearest example. Mounjaro is not recommended during pregnancy, whilst breastfeeding, or in the weeks before trying to conceive. If any of those circumstances arise, stopping quickly and speaking to your GP and prescriber is the right step.

Financial pressure is a more common reason people raise, especially given that Eli Lilly raised Mounjaro's UK list price in September 2025, which pushed private costs higher across the board. If cost is becoming a barrier, talk to your prescriber before you just stop. Pausing, stepping down to a lower dose, or adjusting the frequency of review may all be options worth discussing.

Sometimes people stop simply because they have reached a weight they are happy with and feel ready. That is a completely valid reason. The question worth thinking about in advance is how you plan to sustain those results, and our page on how long you should take Mounjaro is a useful place to work through that thinking before you reach the final pen of a supply. Our guidance on when to stop taking Mounjaro is worth working through carefully, ideally before you reach the final pen of a supply.

If you are at the point of making this decision and would like clinical input before you stop, our prescribers can discuss your situation properly. Speak to our prescribers, a free consultation gives you a considered answer, not a guess.